Concepedia

Lasse Lehtonen

LL

Statistics

Publications

67

Citations

4.9K

H-Index

33

Active since

1986

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

Orion Corporation (Finland)

Hospital District of Helsinki and Uusimaa

University of Eastern Finland

Lasse Lehtonen is an author at Helsinki University Hospital specializing in levosimendan therapy, pharmacology, and medicine.

ORCID

Publications per year

1986–2024

67

Publications

67

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Ferenc Folláth, H. Just, JGY Papp et al. · The Lancet · 2002 · 1.2K citations

, , +12

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

Markku S. Nieminen, Juha Akkila, Franz X. Kleber et al. · Journal of the American College of Cardiology · 2000 · 384 citations

, , +15

Sustained Hemodynamic Effects of Intravenous Levosimendan

Matti Kivikko, Lasse Lehtonen, Wilson S. Colucci · Circulation · 2003 · 258 citations

, , +17

Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure

Matti Kivikko, Saila Antila, Jaan Eha et al. · International Journal of Clinical Pharmacology and Therapeutics · 2002 · 198 citations

, , +16

How to govern the digital transformation of health services

Walter Ricciardi, Pedro Pita Barros, Aleš Bourek et al. · European Journal of Public Health · 2019 · 194 citations · Full text

, , +15

1–5 of 67